Automated Breast Ultrasound Market Size, Share & Trends Analysis Report By Product (ABUS, Automated Breast Volume Scanner), By End Use (Hospitals, Diagnostic Imaging Laboratories), And Segment Forecasts, 2019 - 2026

Report Overview

The global automated breast ultrasound market size was valued at USD 1.2 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 15.0% from 2019 to 2026. The demand for automated breast ultrasound systems is on a rise owing to the rising incidence of cancer, technological advancements, and various initiatives that were undertaken to raise awareness regarding breast cancer and its treatment across the globe.

The increasing prevalence of breast cancer across the globe is anticipated to spur the demand for automated ultrasound over the forecast period. Cancer is the second leading cause of death, globally, and breast cancer is one of the most commonly occurring cancers in women. For instance, as per the Cancer Research U.K., around 55,200 new breast cancer cases were reported in the U.K. every year, from 2014 to 2016. Furthermore, according to the International Agency for Research on Cancer (IARC), WHO, Belgium, Luxemburg, Netherlands, and France are the countries with the highest incidence rate of breast cancer. Such a high incidence rate is anticipated to increase the demand for automated ultrasound systems for further treatment of the condition, thereby propelling market growth over the forecast period.

According to a report published by the Cancer Research U.K. in 2018, breast cancer is the most common cancer in females in the U.K. and around 54,500 new cases were reported in 2016. It also reported that the incidence rate of breast cancer is projected to rise by 2.0% from 2014 to 2035 and around 210 cases per 100,000 females will be reported by 2035. Furthermore, more than 1 in 10 breast cancer cases have been diagnosed in England, Northern Ireland, and Scotland from 2014 to 2016.

Due to the rising prevalence of cancer across the globe, key companies are launching technologically advanced products to strengthen their foothold in the market. For instance, in October 2018, GE Healthcare launched Invenia Automated Breast Ultrasound (ABUS) 2.0 in the U.S. This device was specifically designed to detect cancer in dense tissues overlying the chest. Such factors are anticipated to drive the market over the forecast period.
This increasing incidence rate is due to the rising inclination toward a sedentary lifestyle, obesity, and change in lifestyle habits. Moreover, rising alcohol consumption is expected to increase the risk of this form of cancer. The risk increases by around 7-12% in women who consume three alcoholic drinks per week. The risk can increase by another 10 percent per additional unit of alcohol per day.

Product Insights

Based on the product, the market has been segmented into an automated breast ultrasound system (ABUS) and an automated breast volume scanner. The ABUS segment held the largest market share in 2018 and is anticipated to witness the fastest growth over the forecast period. The growth of the ABUS market is attributable to a large number of products available, technological advancements, and user-friendly features of the device. Some of the products offered by key players are Invenia ABUS 2.0 by GE Healthcare, SOFIA 3D breast ultrasound system by Hitachi Ltd., EPIQ ultrasound system by Koninklijke Philips N.V., and ACUSON S2000 by Siemens Healthineers AG.

The automated breast volume scanner segment is expected to witness moderate growth over the forecast period. The device is used to detect tumors, lesions, and other abnormalities in the tissues overlying the chest. However, these devices are generally operator dependent and the ability to detect accurate results in the first attempt is very less, which is expected to restrain the segment growth. Moreover, rising demand for technologically advanced products for better diagnosis of the condition is also anticipated to impede the segment growth.

End-use Insights

End users in the automated breast ultrasound market are hospitals, diagnostic imaging laboratories, and clinics. The hospital segment held the largest market share in 2018 and is anticipated to witness significant growth over the forecast period. This is owing to rising cases of breast cancer worldwide and the launch of technologically advanced products by key players. Moreover, initiatives undertaken by government and non-profit organizations to raise awareness regarding the disease and its treatment procedure is expected to boost market growth over the forecast period.

The diagnostic imaging laboratory segment is anticipated to witness the fastest growth over the forecast period owing to the increasing number of diagnostic centers. Also, the rising demand for imaging techniques for cancer treatment and the global prevalence of breast cancer are expected to augment the segment growth. Moreover, diagnostic imaging helps doctors analyze a patient’s condition and determine the next course of action. Such factors are expected to boost the demand for diagnostic imaging centers over the forecast period.

Regional Insights

North America held the largest market share in 2018 owing to the rising cases of cancer and the presence of key players in the region. For instance, according to Breastcancer.org, as of January 2019, more than 3.1 million women suffer from breast cancer in the U.S. It also reported that in 2019, about 2,670 new cases of invasive breast cancer are anticipated to be diagnosed in men in the U.S. Such high instance of cancer in the region is expected to drive the market. Besides, the presence of key players such as GE Healthcare, Koninklijke Philips N.V., and Siemens Healthineers AG is expected to drive the market for automated ultrasound systems.

The Asia Pacific market is anticipated to witness the fastest growth over the forecast period owing to the rising awareness regarding this form of cancer and its treatment procedure. For instance, many organizations in the region organize breast cancer awareness campaigns in October to celebrate breast cancer month. These campaigns are also organized to raise funds for research and development of technologically advanced treatment procedures.

Key Companies & Market Share Insights

Key players are involved in adopting strategies such as mergers and acquisitions, collaborations, and partnerships to strengthen their position in the market. For instance, in August 2019, Hologic, Inc. acquired a 46.0% share of SuperSonic Imagine. The acquisition aimed to integrate SuperSonic Imagine’s ultrasound technology and product with Hologic’s resources to develop better and technologically advanced products for breast cancer patients. This acquisition is anticipated to strengthen the foothold of Hologic in the market. Some of the prominent players in the automated breast ultrasound market include:

• General Electric Company

• Hitachi, Ltd.

• Koninklijke Philips N.V.

• Siemens Healthineers AG

• Telemed Medical Systems

• Canon Medical Systems Corporation

• Fukuda Denshi

• Hologic, Inc.

Automated Breast Ultrasound Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2015 to 2026. For this study, Grand View Research has segmented the global automated breast ultrasound market report based on the product, end-use, and region:

• Product Outlook (Revenue, USD Million, 2015 - 2026)

  • Automated Breast Ultrasound System

  • Automated Breast Volume Scanner

• End-use Outlook (Revenue, USD Million, 2015 - 2026)

  • Hospitals

  • Diagnostics Imaging Laboratories

  • Clinics

• Regional Outlook (Revenue, USD Million, 2015 - 2026)

  • North America

    • The U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa

    • Saudi Arabia